ATI LPN
PN ATI Capstone Proctored Comprehensive Assessment 2020 B
1. A nurse is assessing a client with chronic kidney disease. Which of the following findings should the nurse monitor?
- A. Hypokalemia
- B. Fluid overload
- C. Decreased blood pressure
- D. Increased appetite
Correct answer: B
Rationale: The correct answer is B: Fluid overload. Clients with chronic kidney disease are prone to fluid overload due to impaired kidney function. The kidneys may not effectively regulate fluid balance, leading to fluid retention. Monitoring for signs of fluid overload, such as edema, hypertension, and shortness of breath, is crucial. Choice A, Hypokalemia, is less likely in chronic kidney disease as the kidneys often have difficulty excreting potassium, leading to hyperkalemia. Decreased blood pressure (Choice C) is not a common finding in chronic kidney disease unless complications like volume depletion occur. Increased appetite (Choice D) is not typically associated with chronic kidney disease; in fact, many clients may experience a decreased appetite due to various factors such as uremia and dietary restrictions.
2. A nurse is caring for a client who is receiving total parenteral nutrition (TPN). Which of the following assessment findings requires immediate intervention by the nurse?
- A. Prealbumin level of 20 mg/dL
- B. Weight increase of 2 kg/day
- C. Temperature of 37.6°C
- D. Blood glucose level of 120 mg/dL
Correct answer: B
Rationale: A rapid weight gain of 2 kg/day suggests fluid overload, a possible complication of TPN. This requires immediate intervention to prevent further complications such as pulmonary edema. The other options are not indicative of immediate complications related to TPN. A low prealbumin level may indicate malnutrition but does not require immediate intervention. A slightly elevated temperature and blood glucose level are within normal ranges and do not warrant immediate action.
3. A nurse is preparing to administer a dose of enoxaparin. Which of the following actions should the nurse take?
- A. Administer it intramuscularly
- B. Monitor APTT levels
- C. Give it in the abdomen
- D. Administer rapidly
Correct answer: C
Rationale: The correct answer is to give enoxaparin in the abdomen. Enoxaparin is usually administered subcutaneously in the abdomen to avoid muscle irritation. Choice A is incorrect because enoxaparin should not be administered intramuscularly. Choice B is incorrect as monitoring APTT levels is not directly related to administering enoxaparin. Choice D is incorrect as enoxaparin should be administered slowly to prevent bruising or bleeding at the injection site.
4. A school nurse is developing a teaching plan about testicular cancer for a group of adolescents. What information should the nurse include in the teaching?
- A. Expect pain in the testicles during self-examination.
- B. The testicles should be uniform in size and shape when examined.
- C. Expect testicles to be uniform in consistency when performing a testicular self-examination.
- D. The testicles will shrink if cancer is present.
Correct answer: C
Rationale: The correct answer is C because during a testicular self-examination, it is crucial to note a uniform consistency of the testicles. Any lumps, changes in size, or inconsistencies should be reported to a healthcare provider promptly. Choice A is incorrect because pain is not typically expected during a testicular self-examination. Choice B is incorrect as uniform size and shape are not as relevant as uniform consistency. Choice D is incorrect; testicular cancer usually causes enlargement rather than shrinking of the testicles.
5. A nurse is teaching a client about the use of levetiracetam. Which of the following should be included in the teaching?
- A. It can cause weight loss
- B. Monitor for mood changes
- C. It is an over-the-counter medication
- D. It has no side effects
Correct answer: B
Rationale: The correct answer is B. Levetiracetam can cause mood changes and behavioral side effects, so clients should be monitored for these effects. Choice A is incorrect because levetiracetam is not typically associated with weight loss. Choice C is incorrect as levetiracetam is a prescription medication, not available over the counter. Choice D is incorrect as all medications, including levetiracetam, have potential side effects.
Similar Questions
Access More Features
ATI LPN Basic
$69.99/ 30 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access
ATI LPN Premium
$149.99/ 90 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access